Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients | Breast Cancer | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
1.
DeSantis  CE, Fedewa  SA, Goding Sauer  A, Kramer  JL, Smith  RA, Jemal  A.  Breast cancer statistics, 2015.   CA Cancer J Clin. 2016;66(1):31-42. doi:10.3322/caac.21320 PubMedGoogle ScholarCrossref
2.
Kohler  BA, Sherman  RL, Howlader  N,  et al.  Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state.   J Natl Cancer Inst. 2015;107(6):djv048. doi:10.1093/jnci/djv048 PubMedGoogle Scholar
3.
Newman  LA, Reis-Filho  JS, Morrow  M, Carey  LA, King  TA.  The 2014 Society of Surgical Oncology Susan G. Komen for the Cure symposium.   Ann Surg Oncol. 2015;22(3):874-882. doi:10.1245/s10434-014-4279-0 PubMedGoogle ScholarCrossref
4.
Bellio  G, Marion  R, Giudici  F,  et al.  Interval breast cancer versus screen-detected cancer.   Clin Breast Cancer. 2017;17(7):564-571. doi:10.1016/j.clbc.2017.04.001 PubMedGoogle ScholarCrossref
5.
O’Brien  KM, Mooney  T, Fitzpatrick  P, Sharp  L.  Screening status, tumour subtype, and breast cancer survival.   Breast Cancer Res Treat. 2018;172(1):133-142. doi:10.1007/s10549-018-4877-9 PubMedGoogle ScholarCrossref
6.
Puvanesarajah  S, Nyante  SJ, Kuzmiak  CM,  et al.  PAM50 and risk of recurrence scores for interval breast cancers.   Cancer Prev Res (Phila). 2018;11(6):327-336. doi:10.1158/1940-6207.CAPR-17-0368 PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Research Letter
    February 19, 2020

    Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients

    Author Affiliations
    • 1Henry Ford Cancer Institute, Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan
    • 2Department of Surgery, Weill Cornell Medicine, New York, New York
    • 3Henry Ford Cancer Institute, Department of Surgery, Henry Ford Health System, Detroit, Michigan
    JAMA Surg. 2020;155(5):440-442. doi:10.1001/jamasurg.2019.6032
    ×